Birch Eileen E, Jost Reed M, Kelly Krista R
Pediatric Vision Laboratory, Retina Foundation of the Southwest, Dallas, Texas; Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas.
Pediatric Vision Laboratory, Retina Foundation of the Southwest, Dallas, Texas.
J AAPOS. 2025 Feb;29(1):104116. doi: 10.1016/j.jaapos.2025.104116. Epub 2025 Jan 24.
One rationale for dichoptic amblyopia therapy is that it may promote recovery of binocular function. Yet data on binocular outcomes in anisometropic amblyopia following dichoptic therapy are sparse. We report factors associated with pre- and post-treatment binocular function in anisometropic amblyopia, and examine binocular function in children who recover normal visual acuity compared to those with residual amblyopia.
Baseline and outcome stereoacuity and binocular function (BF) scores were pooled across 185 children (3-12 years of age) with anisometropic amblyopia who participated in one of eight clinical trials of contrast-rebalanced dichoptic amblyopia treatment conducted at a single site. Associations of baseline variables (visual acuity, suppression, type and amount of anisometropia, prior treatment) with baseline and outcome stereoacuity and BF scores were analyzed, as well the association between improvement in visual acuity with improvement in stereoacuity and BF scores.
Better baseline stereoacuity and BF score were associated with better baseline visual acuity, less baseline suppression, less anisometropia, and anisometropia due to astigmatism. Better outcome stereoacuity and BF score were associated with better baseline stereoacuity and BF score, more improvement in visual acuity, less anisometropia, and anisometropia due to astigmatism. Children aged 3-6 years who recovered normal visual acuity with dichoptic treatment had better stereoacuity and BF score outcomes than those with residual amblyopia.
Dichoptic therapy is an effective amblyopia treatment. Although there was no substantive advantage in promoting binocular function, stereoacuity outcomes were similar to those previously reported for patching and Bangerter filters.
双眼弱视治疗的一个基本原理是它可能促进双眼视功能的恢复。然而,关于屈光参差性弱视双眼治疗后双眼视功能结果的数据很少。我们报告了屈光参差性弱视治疗前后双眼视功能相关的因素,并比较了视力恢复正常的儿童与仍有弱视残留的儿童的双眼视功能。
对185名3至12岁患有屈光参差性弱视的儿童的基线和结果立体视锐度及双眼视功能(BF)评分进行汇总,这些儿童参与了在单一地点进行的八项对比平衡双眼弱视治疗临床试验中的一项。分析基线变量(视力、抑制、屈光参差的类型和程度、既往治疗)与基线和结果立体视锐度及BF评分之间的关联,以及视力改善与立体视锐度和BF评分改善之间的关联。
更好的基线立体视锐度和BF评分与更好的基线视力、更少的基线抑制、更少的屈光参差以及散光性屈光参差有关。更好的结果立体视锐度和BF评分与更好的基线立体视锐度和BF评分、视力的更大改善、更少的屈光参差以及散光性屈光参差有关。接受双眼治疗后视力恢复正常的3至6岁儿童的立体视锐度和BF评分结果优于仍有弱视残留的儿童。
双眼治疗是一种有效的弱视治疗方法。虽然在促进双眼视功能方面没有实质性优势,但立体视锐度结果与先前报道的遮盖疗法和班格特滤光镜的结果相似。